HXT7 Antibody

What is HXT7 and why is it important in yeast research?

HXT7 is a high-affinity glucose transporter belonging to the HXT family in Saccharomyces cerevisiae. The significance of HXT7 lies in its glucose-dependent regulation and critical role in yeast metabolism. It shows relatively low expression during exponential growth at high glucose concentrations but increases sharply when glucose concentrations fall below 20 mM . This glucose-dependent expression pattern makes HXT7 an excellent model for studying nutrient sensing and metabolic adaptation in eukaryotic cells. The protein remains stable even after glucose exhaustion, while its mRNA levels decline rapidly, suggesting complex post-transcriptional regulation . Researchers targeting HXT7 can gain insights into fundamental cellular processes including carbon source utilization, metabolic reprogramming, and nutrient signaling pathways.

What types of HXT7 antibodies are available for research applications?

While the search results don't specifically detail HXT7 antibody types, based on standard research practices, several antibody formats are typically employed for studying yeast membrane proteins like HXT7:

• Polyclonal antibodies: These recognize multiple epitopes on HXT7 and are useful for general detection and immunoprecipitation experiments. They can be generated against full-length HXT7 or specific peptide regions.

• Monoclonal antibodies: These target specific epitopes on HXT7 and provide consistent results across experiments with high specificity.

• Tagged antibodies: Secondary antibodies conjugated with enzymes (HRP, alkaline phosphatase), fluorophores, or gold particles for different detection methods.

The selection should be based on specific experimental requirements, such as whether the researcher needs to detect native HXT7 in cellular fractions or recombinant versions with epitope tags. The research by Ye et al. utilized goat anti-rabbit antibodies from BioRad for their detection system .

How is HXT7 expression regulated in yeast cells?

HXT7 expression in yeast follows a sophisticated regulatory pattern dependent on glucose availability. In wild-type strains, HXT7 is repressed at high glucose concentrations (>30 mM) but highly expressed at lower glucose concentrations (particularly below 5 mM) . This regulation involves:

• Promoter regions: A critical 149 bp region (between positions -495 and -346 relative to the start codon) is essential for HXT7 expression. Deletion of this region drastically reduces both mRNA and protein levels .

• Transcription factors: The HXT7 promoter contains binding sites for glucose-responsive transcription factors, including two binding sites for Adrl, a transcriptional activator of glucose-repressed genes .

• Glucose sensing: The Snf3 protein likely functions as a low glucose sensor that may detect internal glucose levels or glycolytic intermediates to regulate HXT7 expression .

• Cross-regulation: The presence of other HXT genes appears to repress HXT7 expression at high glucose concentrations, suggesting a complex regulatory network among hexose transporters .

Upon glucose exhaustion, HXT7 mRNA levels decline rapidly while the protein remains stable for at least 2 hours, indicating different turnover rates for the mRNA and protein products .

What are the optimal methods for detecting HXT7 protein using antibodies?

For optimal detection of HXT7 protein using antibodies, researchers should consider the following methodological approaches:

Western Blot Analysis:

• Sample preparation: Carefully extract membrane proteins using detergent-based lysis buffers that preserve membrane protein integrity

• Gel selection: Use 10-12% SDS-PAGE gels for optimal resolution of HXT7 (approximately 63 kDa)

• Transfer conditions: Employ semidry or wet transfer methods with methanol-containing buffers to efficiently transfer hydrophobic membrane proteins

• Blocking: Use 5% non-fat milk or BSA in TBS-T for 1-2 hours to minimize background

• Antibody incubation: Apply primary HXT7 antibody (typically 1:1000-1:5000 dilution) overnight at 4°C

• Detection: Use appropriate secondary antibodies conjugated to HRP followed by ECL detection

In the research conducted by Ye et al., they successfully detected Hxt7 protein expression patterns during different growth phases and glucose concentrations using antibody-based methods. Their results showed that Hxt7 protein levels remained high even after glucose exhaustion, unlike mRNA levels which declined rapidly .

Immunofluorescence Microscopy:

• Fixation: Use formaldehyde fixation (typically 3.7%) followed by spheroplasting with zymolyase

• Permeabilization: Treat with detergent solutions (0.1% Triton X-100) to allow antibody access

• Blocking: Apply 1-3% BSA to reduce non-specific binding

• Primary antibody: Incubate with anti-HXT7 antibody (1:100-1:500) for 1-2 hours

• Secondary antibody: Use fluorophore-conjugated secondary antibodies for visualization

• Counterstaining: Include DAPI for nuclear visualization

When interpreting results, researchers should be aware that HXT7 localization patterns change depending on glucose availability and growth conditions.

How should samples be prepared for optimal HXT7 antibody binding in immunoblotting?

Optimal sample preparation for HXT7 immunoblotting requires specific considerations for this membrane-bound glucose transporter:

Cell Harvesting and Lysis:

• Harvest cells at specific time points during growth to capture different expression levels. As demonstrated by Ye et al., HXT7 expression varies significantly with glucose concentration and growth phase .

• Rapidly cool cultures in ice to prevent protein degradation and changes in expression.

• Wash cells in cold buffer containing protease inhibitors.

• For membrane protein extraction, use either glass bead disruption or enzymatic spheroplasting followed by mechanical disruption.

Membrane Fraction Isolation:

• Remove cell debris by centrifugation at low speed (1,000-3,000g).

• Collect membrane fractions by ultracentrifugation (100,000g for 60 minutes).

• Resuspend membrane pellets in buffer containing 1% detergent (Triton X-100, DDM, or CHAPS) to solubilize membrane proteins.

Protein Denaturation:

• Add sample buffer containing SDS and reducing agents.

• Heat samples at 37°C (not boiling) for 10 minutes to prevent aggregation of membrane proteins.

• Include urea (up to 8M) in difficult cases to improve solubilization.

Loading Controls:

• Include appropriate loading controls such as Pma1 (plasma membrane ATPase) or another constitutively expressed membrane protein.

• Normalize protein loading to 20-50 μg total protein per lane.

The experimental approach used by Ye et al. involved synchronizing sample collection with growth curves and glucose consumption patterns, demonstrating that timing is critical for capturing dynamic HXT7 expression .

What are the key considerations when designing immunoprecipitation experiments with HXT7 antibodies?

When designing immunoprecipitation (IP) experiments targeting HXT7, researchers should consider these critical factors:

Membrane Protein Solubilization:

• Select appropriate detergents that maintain HXT7 native conformation while effectively solubilizing from membranes

• Optimize detergent concentration (typically 0.5-2%) - too high can denature the protein, too low yields poor extraction

• Consider digitonin, DDM, or CHAPS as mild detergents suitable for membrane protein IP

Antibody Selection and Validation:

• Verify antibody specificity using HXT7 deletion strains (as described in the research with hxt null strains)

• Test antibody efficiency in preliminary Western blots before attempting IP

• Consider using epitope-tagged HXT7 constructs if native protein antibodies show cross-reactivity with other HXT family members

Optimizing IP Conditions:

• Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Determine optimal antibody-to-lysate ratios through titration experiments

• Incubate overnight at 4°C with gentle rotation to maximize specific binding

• Include appropriate controls:

  • Non-specific IgG control

  • Lysate from HXT7 deletion strain

  • Input sample for comparison

Elution Strategies:

• Use either acidic elution (glycine buffer, pH 2.5-3.0)

• Consider specific peptide elution if epitope is known

• When analyzing post-translational modifications, avoid reducing agents in elution buffers if studying disulfide bonds

Co-Immunoprecipitation Considerations:

• Adjust detergent and salt concentrations to preserve protein-protein interactions

• Cross-linking may be necessary to capture transient interactions

• Sequential IPs can be used to identify specific complexes

Since HXT7 expression is strongly regulated by glucose concentrations, collect samples at appropriate time points based on the glucose consumption pattern to capture the desired expression state .

How can HXT7 antibodies be used to investigate glucose transport regulation in different yeast mutants?

HXT7 antibodies provide powerful tools for investigating glucose transport regulation in yeast mutant strains through several advanced approaches:

Comparative Expression Analysis:

• Use HXT7 antibodies to quantify protein levels across multiple mutant strains with varying glucose sensing or metabolism pathways

• Compare HXT7 expression between wildtype and mutant strains under identical growth conditions

• Correlate protein levels with growth rates and glucose consumption patterns

This approach was effectively demonstrated in the work by Ye et al., who showed that HXT7 expression in the wildtype strain MC996A at high glucose concentrations was lower than in HXT7-only strains (RE607B, LYYO, LYY4, LYY8), suggesting regulatory effects from other HXT genes .

Tracking Protein Degradation and Stability:

• Perform pulse-chase experiments with cycloheximide to block new protein synthesis

• Use antibodies to monitor HXT7 degradation rates in different mutant backgrounds

• Examine HXT7 stability under various stress conditions or nutrient states

Research has shown that Hxt7 protein remains stable for at least 2 hours after glucose exhaustion while its mRNA levels decline rapidly, indicating differential regulation of synthesis versus degradation .

Subcellular Localization Studies:

• Employ immunofluorescence microscopy or subcellular fractionation followed by immunoblotting

• Track HXT7 trafficking between internal compartments and plasma membrane

• Investigate how mutations in trafficking machinery affect HXT7 localization

Promoter-Activity Correlation Studies:

• Combine promoter mutation analysis with antibody detection of protein levels

• Create a panel of strains with varying HXT7 promoter lengths (as in Ye's work with deletions between -495 and -346 bp) and quantify protein expression

• Correlate specific promoter elements with protein expression levels under different glucose concentrations

Protein-Protein Interaction Networks:

• Use co-immunoprecipitation with HXT7 antibodies to identify interaction partners

• Compare interactomes between wildtype and mutant strains

• Validate interactions with reverse co-IP experiments and proximity ligation assays

This multifaceted approach connects genetic manipulation, protein detection, and functional outcomes to build comprehensive models of glucose sensing and transport regulation in yeast.

What methodological approaches can be used to distinguish HXT7 from other highly similar HXT family members?

Distinguishing HXT7 from other HXT family members, particularly its close homolog HXT6, presents a significant challenge in yeast research. Here are methodological approaches utilizing antibodies and complementary techniques:

Epitope Mapping and Antibody Generation:

• Identify unique regions in HXT7 sequence that differ from other HXT proteins

• Generate peptide antibodies against these unique epitopes

• Validate specificity using strain panels:

  • Wildtype strains

  • Single deletion strains (Δhxt7)

  • Multiple deletion strains (as described in the research with hxt1-hxt7 deletion strains)

Immunoprecipitation Combined with Mass Spectrometry:

• Perform IP with potentially cross-reactive antibodies

• Analyze precipitated proteins by mass spectrometry

• Identify peptides unique to HXT7 to confirm identity

Genetic Engineering Approaches:

• Create epitope-tagged versions of HXT7 (HA, FLAG, or Myc tags)

• Use tag-specific antibodies for unambiguous detection

• Engineer strains with single HXT transporters, similar to the approach used by Ye et al. with HXT7 promoter deletion strains

Pre-absorption Strategy:

• Pre-incubate antibodies with recombinant proteins or peptides from related HXT members

• Use the pre-absorbed antibody to detect remaining reactivity (specific to HXT7)

Two-dimensional Gel Electrophoresis:

• Separate HXT family members by isoelectric point and molecular weight

• Perform Western blotting on 2D gels

• Identify specific spots corresponding to HXT7

Expression Pattern Differentiation:

• Exploit the unique expression patterns of different HXT transporters

• HXT7 shows specific expression patterns related to glucose concentration - low during high glucose growth and sharply increased at glucose concentrations below 20 mM

• Compare antibody signals across various growth conditions where expression profiles of HXT members differ

Controls for Validation:

• Use the hxt null strain (like KY73 with null alleles in HXT1-HXT7 and GAL2 genes)

• Include genetic complementation with specific HXT genes to confirm signal specificity

• Perform parallel analysis of mRNA (Northern blot) and protein (Western blot) to correlate expression patterns

These combined approaches can effectively differentiate HXT7 from other HXT family members despite their sequence similarity.

How can researchers investigate post-translational modifications of HXT7 using antibody-based approaches?

Investigating post-translational modifications (PTMs) of HXT7 using antibody-based approaches requires specialized methodologies:

Phosphorylation Analysis:

• Immunoprecipitate HXT7 using specific antibodies under non-denaturing conditions

• Perform Western blotting with anti-phospho antibodies (phospho-serine, phospho-threonine, or phospho-tyrosine)

• Alternatively, use Phos-tag™ SDS-PAGE to separate phosphorylated from non-phosphorylated forms, followed by HXT7 antibody detection

• Compare phosphorylation patterns under different glucose concentrations, as HXT7 expression and possibly its PTMs change dramatically with glucose availability

Ubiquitination Detection:

• Perform immunoprecipitation with HXT7-specific antibodies

• Probe blots with anti-ubiquitin antibodies to detect ubiquitinated forms

• Use proteasome inhibitors (MG132) to accumulate ubiquitinated species

• Compare ubiquitination patterns during high glucose (where HXT7 expression is lower) and low glucose conditions

Glycosylation Analysis:

• Treat immunoprecipitated HXT7 with glycosidases (PNGase F, Endo H)

• Observe mobility shifts via Western blotting

• Use lectin-based detection methods as complementary approaches

Generation of Modification-Specific Antibodies:

• Develop antibodies against specific modified peptides from HXT7

• Validate using synthetic phosphopeptides and non-phosphorylated controls

• Apply to samples from different growth phases to track modification dynamics

Mass Spectrometry Validation:

• Use antibodies to immunoprecipitate HXT7

• Perform LC-MS/MS analysis to identify and map specific modifications

• Quantify modification stoichiometry under different conditions

Two-dimensional Electrophoresis:

• Separate proteins by isoelectric point and molecular weight

• Use HXT7 antibodies to detect different modified forms as distinct spots

• Compare patterns between different growth conditions and genetic backgrounds

Correlation with Functional Outputs:

• Combine PTM detection with glucose transport assays

• Correlate modifications with protein stability measurements

• Study how modifications change during glucose depletion, when HXT7 protein remains stable despite mRNA decline

These methods can provide insights into how post-translational modifications regulate HXT7 function, localization, and stability during changing glucose conditions.

How should researchers address cross-reactivity issues with HXT7 antibodies?

Cross-reactivity is a significant challenge when working with HXT7 antibodies due to high sequence similarity among HXT family members. Here's a comprehensive troubleshooting approach:

Diagnostic Steps for Identifying Cross-Reactivity:

• Test antibody specificity using a panel of yeast strains:

  • Wildtype strains

  • Δhxt7 single deletion strain

  • Multiple HXT deletion strains (similar to the hxt1-hxt7 deletion strain KY73 described in the literature)

  • Strains expressing only HXT7 (like RE607B with HXT1-HXT6 inactivated)

• Observe band patterns:

  • Multiple bands near expected molecular weight suggest cross-reactivity

  • Bands appearing in Δhxt7 strains confirm non-specific binding

Methodological Solutions:

• Antibody Purification:

  • Perform affinity purification using recombinant HXT7-specific peptides

  • Use subtractive approaches with non-target HXT proteins

• Pre-absorption Strategy:

  • Pre-incubate antibody with lysates from Δhxt7 strains

  • Use recombinant proteins of highly similar HXT members for pre-absorption

• Epitope Mapping:

  • Identify unique epitopes in HXT7 not present in other HXT proteins

  • Generate new antibodies against these regions

• Modified Immunoblotting Conditions:

  • Increase stringency with higher salt concentrations (150-500 mM NaCl)

  • Adjust detergent concentration in washing buffers

  • Reduce primary antibody concentration

  • Shorten incubation time

• Alternative Detection Strategies:

  • Use epitope-tagged HXT7 constructs

  • Consider proximity ligation assays with dual antibody recognition

Data Interpretation Guidelines:

• Always include appropriate controls in each experiment

• Interpret bands with caution when studying specific HXT7 expression patterns

• Correlate protein data with mRNA levels (Northern blot) as shown in the Ye et al. study

• Consider relative expression rather than absolute values when cross-reactivity cannot be eliminated

• Use multiple antibodies targeting different epitopes to confirm findings

Validation Through Complementary Approaches:

• Corroborate antibody-based results with functional assays

• Confirm with mass spectrometry identification

• Use genetic approaches like the HXT7 promoter deletion series to create strains with differential expression for antibody validation

Addressing cross-reactivity systematically ensures more reliable interpretation of HXT7 expression patterns across experimental conditions.

What controls are essential when using HXT7 antibodies for quantitative analysis of protein expression?

For rigorous quantitative analysis of HXT7 protein expression using antibodies, researchers should implement the following essential controls:

Genetic Controls:

• Deletion strain control: Include Δhxt7 strain samples to verify antibody specificity and establish background signal levels

• HXT7-only strain: Use strains expressing only HXT7 (like RE607B) as positive controls

• Titration series: Generate strains with varying HXT7 expression levels (like the promoter deletion series with different copy numbers) to create a reference standard curve

Sample Processing Controls:

• Extraction efficiency control: Include spike-in controls with known quantities of recombinant HXT7 or tagged variants

• Membrane fraction validation: Use established membrane protein markers (e.g., Pma1) to confirm consistent extraction of membrane proteins

• Total protein normalization: Validate with Ponceau S or SYPRO Ruby staining before immunoblotting

Antibody-Related Controls:

• Concentration titration: Establish the linear detection range of the antibody by titrating both antibody and protein amounts

• Secondary antibody-only: Include samples without primary antibody to assess non-specific binding

• Pre-immune serum control: For polyclonal antibodies, include the pre-immune serum at equivalent concentration

Quantification Controls:

• Internal reference proteins: Include constitutively expressed proteins not affected by experimental conditions

• Dilution series: Prepare a dilution series of a reference sample to establish a standard curve

• Technical replicates: Analyze the same sample multiple times to assess technical variability

Biological Condition Controls:

• Time course verification: Sample at multiple time points to capture the dynamic expression pattern of HXT7, which changes dramatically with glucose concentration

• Glucose concentration verification: Monitor actual glucose levels in the medium, as HXT7 expression is heavily dependent on glucose availability

• Growth phase standardization: Normalize collection times to growth phase rather than absolute time

Data Analysis Controls:

• Exposure optimization: Capture multiple exposure times to ensure signals fall within the linear range

• Software validation: Use multiple quantification methods/software to confirm density measurements

• Statistical controls: Apply appropriate statistical tests with multiple biological replicates

Implementing these controls allows researchers to generate quantitatively robust data about HXT7 expression patterns, enabling meaningful comparisons across experimental conditions and genetic backgrounds.

How can researchers correlate HXT7 protein levels with its functional activity in glucose transport?

Correlating HXT7 protein levels with functional glucose transport activity requires integrating antibody-based quantification with functional assays. Here's a comprehensive methodological approach:

Integrated Experimental Design:

• Culture cells under controlled conditions with defined glucose concentrations

• Collect parallel samples at identical time points for:

  • Protein quantification (Western blot)

  • Glucose uptake assays

  • mRNA analysis

  • Growth rate measurements

Research by Ye et al. demonstrated this approach by simultaneously measuring growth curves, glucose consumption patterns, and HXT7 expression levels in various strains .

Protein Quantification Methods:

• Use calibrated Western blotting with HXT7-specific antibodies

• Implement internal standards and loading controls

• Perform quantitative immunofluorescence to assess cell-to-cell variation

• Determine the proportion of HXT7 at the plasma membrane versus internal compartments

Functional Activity Measurements:

• Glucose uptake assays:

  • Short-term uptake of radio-labeled glucose (e.g., [14C]-glucose)

  • Kinetic analysis to determine Vmax and Km values

  • Competition assays with non-labeled glucose

• Growth rate correlation:

  • Monitor growth in defined glucose concentrations

  • Calculate specific growth rates

  • Measure residual glucose in media over time

  Ye et al. observed that growth rates correlated with HXT7 expression levels in their promoter deletion strains, suggesting a direct relationship between transporter abundance and functional capacity .

• Fluorescent glucose analogues:

  • Use 2-NBDG (fluorescent glucose analogue) uptake

  • Flow cytometry analysis of transport activity

  • Live-cell imaging of uptake rates

Data Integration Approaches:

• Plot HXT7 protein levels against glucose uptake rates

• Perform regression analysis to establish quantitative relationships

• Create mathematical models incorporating:

  • Protein expression levels

  • Membrane localization

  • Transport kinetics

  • Growth parameters

Genetic Manipulation Strategies:

• Use the promoter deletion series to create strains with predictable HXT7 expression levels

• Implement controlled expression systems (e.g., tetracycline-inducible promoters)

• Generate point mutations affecting transport without altering expression

Validation Through Heterologous Expression:

• Express HXT7 in a heterologous system lacking endogenous glucose transporters

• Measure both protein levels and transport activity

• Establish a baseline correlation in a simplified system

What are the key considerations for interpreting conflicting HXT7 expression data between mRNA and protein levels?

When facing discrepancies between HXT7 mRNA and protein measurements, researchers should consider several biological and technical factors:

Biological Explanations for Discrepancies:

• Differential Stability Mechanisms:

  • Ye et al. directly observed that HXT7 mRNA declined rapidly after glucose exhaustion while the protein remained stable for at least 2 hours

  • This demonstrates fundamentally different turnover rates for mRNA versus protein

• Post-transcriptional Regulation:

  • mRNA may be transcribed but not efficiently translated

  • Regulatory RNA-binding proteins might inhibit translation under specific conditions

  • miRNA regulation could affect translation efficiency without changing mRNA levels

• Protein Trafficking and Compartmentalization:

  • Changes in protein localization (internal vesicles vs. plasma membrane) may affect antibody accessibility

  • Total protein levels might remain constant while functional surface-exposed protein changes

• Temporal Considerations:

  • Protein synthesis occurs after mRNA production, creating a time lag

  • In dynamic systems like glucose-responsive HXT7 expression, this delay can be significant

  • Sample timing relative to glucose concentration changes is critical

Technical Considerations for Resolving Discrepancies:

• Method Validation:

  • Confirm antibody specificity using appropriate controls (HXT7 deletion strains)

  • Verify Northern blot probe specificity, especially given sequence similarity among HXT genes

  • Evaluate detection limits of both methods

• Sample Preparation Differences:

  • RNA extraction efficiency may differ from protein extraction efficiency

  • Membrane protein extraction requires specific protocols that may vary in effectiveness

• Integrated Experimental Approaches:

  • Collect samples for both RNA and protein from the same culture

  • Perform dense time-course sampling to capture transition points

  • Monitor glucose levels simultaneously to correlate with expression changes

• Quantification Methods:

  • Use absolute quantification methods where possible (qPCR, quantitative Western blotting)

  • Apply consistent normalization strategies across experiments

  • Employ multiple detection methods to confirm findings

Interpretive Framework:

• Consider which measurement better reflects the functional state (typically protein)

• Evaluate which measurement correlates better with physiological outcomes

• Use mathematical models to account for synthesis and degradation rates

• Calculate expected protein levels based on mRNA abundance and compare to observed values

Understanding these discrepancies is particularly relevant for HXT7 research because the protein's expression is highly regulated by glucose concentration, and mRNA/protein correlation varies significantly across growth conditions as demonstrated in the comprehensive glucose consumption and expression studies by Ye et al. .

How can HXT7 antibodies be utilized in single-cell studies of yeast heterogeneity?

Single-cell analysis of HXT7 expression using antibody-based approaches can reveal population heterogeneity in yeast cultures, providing insights into metabolic diversity and cell-to-cell variation in glucose sensing and transport capacity. Here are methodological approaches for this emerging research direction:

Flow Cytometry-Based Applications:

• Intracellular Staining Protocol:

  • Fix cells with formaldehyde or methanol

  • Permeabilize cell wall with zymolyase followed by detergent treatment

  • Stain with fluorophore-conjugated HXT7 antibodies or primary/secondary antibody combinations

  • Analyze using flow cytometry to quantify cell-to-cell variation

• Multi-parameter Analysis:

  • Combine HXT7 staining with metabolic activity indicators (e.g., CFDA for enzyme activity)

  • Include cell cycle markers to correlate HXT7 expression with cell cycle phase

  • Add mitochondrial dyes to assess respiratory status alongside HXT7 levels

High-Content Microscopy Approaches:

• Quantitative Immunofluorescence:

  • Immobilize cells on coated slides or in microfluidic devices

  • Perform immunofluorescence using HXT7 antibodies

  • Capture images using automated microscopy

  • Apply image analysis algorithms to quantify signal intensity and localization at single-cell level

• Time-lapse Experiments:

  • Use microfluidic devices to trap individual cells

  • Apply glucose concentration gradients or dynamic changes

  • Perform periodic fixation and antibody staining

  • Track HXT7 expression changes in lineages over time

Microfluidic Single-Cell Western Blotting:

• Capture single cells in microfluidic chambers

• Perform in situ lysis and electrophoresis

• Transfer proteins to capture membrane within the device

• Probe with HXT7 antibodies

• Quantify protein levels in individual cells

Single-Cell Immunoprecipitation Mass Spectrometry:

• Sort single cells or small populations based on reporter fluorescence

• Perform miniaturized immunoprecipitation with HXT7 antibodies

• Analyze by sensitive mass spectrometry methods

• Identify post-translational modifications and interacting partners at single-cell level

Correlation with Single-Cell Transcriptomics:

• Split samples for parallel antibody-based protein detection and scRNA-seq

• Develop computational methods to integrate protein and mRNA data

• Identify subpopulations with discordant mRNA/protein levels

Microfluidic Glucose Uptake Assays:

• Immobilize single cells in microchannels

• Expose to fluorescent glucose analogs

• Simultaneously measure HXT7 levels via antibody staining

• Correlate transporter abundance with functional uptake at single-cell resolution

This emerging field builds upon the foundational work on HXT7 expression and regulation , extending it to understand how individual cells within a population might differentially express and utilize this high-affinity glucose transporter under varying environmental conditions.

What are the latest methodological advances for studying HXT7 protein-protein interactions using antibody-based approaches?

Recent methodological advances have significantly enhanced the capability to study HXT7 protein-protein interactions using antibody-based approaches. These cutting-edge techniques provide researchers with powerful tools to dissect the molecular interactome of this important glucose transporter:

Proximity-Dependent Labeling Methods:

• BioID/TurboID with HXT7:

  • Generate fusion proteins of HXT7 with biotin ligase enzymes

  • Express in yeast under native regulation

  • Activate with biotin to label proximal proteins

  • Use streptavidin pull-down followed by mass spectrometry

  • Antibodies against HXT7 can validate the expression and localization of fusion proteins

• APEX2 Proximity Labeling:

  • Create HXT7-APEX2 fusions

  • Briefly treat cells with hydrogen peroxide and biotin-phenol

  • Capture biotinylated proximal proteins

  • Verify system using HXT7 antibodies for expression control

Advanced Co-Immunoprecipitation Techniques:

• Crosslinking Mass Spectrometry (XL-MS):

  • Apply membrane-permeable crosslinkers to intact yeast cells

  • Immunoprecipitate HXT7 complexes using specific antibodies

  • Analyze by specialized XL-MS protocols

  • Identify not just interacting partners but spatial constraints within complexes

• Antibody-based Protein Correlation Profiling:

  • Fractionate yeast membranes under native conditions

  • Track HXT7 distribution using specific antibodies

  • Identify proteins with matching distribution profiles by mass spectrometry

  • Infer interactions based on co-fractionation patterns

Microscopy-Based Interaction Methods:

• Proximity Ligation Assay (PLA):

  • Use primary antibodies against HXT7 and suspected interaction partners

  • Apply species-specific PLA probes with attached oligonucleotides

  • Amplify signal when proteins are in close proximity (<40 nm)

  • Visualize as distinct spots by fluorescence microscopy

• FRET with Antibody Fragments:

  • Develop Fab fragments from HXT7 antibodies labeled with donor fluorophores

  • Label putative interaction partners with acceptor fluorophores

  • Measure energy transfer as indicator of proximity

  • Particularly useful for membrane protein interactions

Split Reporter Systems with Antibody Validation:

• Split Luciferase Complementation:

  • Fuse HXT7 and potential partners to luciferase fragments

  • Measure luminescence when interaction brings fragments together

  • Use antibodies to confirm expression levels for normalization

  • Particularly effective for dynamic interaction studies

• Split Fluorescent Protein Systems:

  • Create fusions with split GFP/YFP fragments

  • Visualize interactions through fluorescence complementation

  • Validate with antibodies against native proteins in parallel experiments

These advanced methodologies can be applied to investigate how HXT7 interactions change under different glucose concentrations, building on the understanding that HXT7 expression and function is highly dependent on glucose availability as demonstrated in previous research .

How can researchers utilize HXT7 antibodies in studying the relationship between glucose transport and aging in yeast?

Investigating the relationship between HXT7-mediated glucose transport and yeast aging requires specialized antibody-based approaches that connect transporter function with longevity mechanisms:

Chronological Lifespan Studies:

• Age-dependent Expression Profiling:

  • Culture yeast in batch for extended periods (up to several weeks)

  • Collect samples at defined intervals throughout chronological aging

  • Quantify HXT7 levels using calibrated Western blotting

  • Correlate expression with cell viability and metabolic activity

  This approach builds on observations that HXT7 expression changes dramatically with glucose availability , potentially influencing the aging process through altered nutrient sensing.

• Subcellular Localization During Aging:

  • Use immunofluorescence microscopy to track HXT7 localization in aging cells

  • Employ co-staining with organelle markers to detect age-related mislocalization

  • Quantify surface-exposed versus internal HXT7 pools using antibody accessibility assays

Replicative Lifespan Analysis:

• Mother-Daughter Expression Asymmetry:

  • Isolate mother cells of increasing replicative age using micromanipulation or biotin labeling

  • Perform immunofluorescence with HXT7 antibodies

  • Analyze whether HXT7 is asymmetrically retained in mother cells or segregated to daughters

  • Correlate patterns with replicative potential

• Single-Cell Aging Trajectories:

  • Use microfluidic devices to trap mother cells for whole-lifespan imaging

  • Apply fixation and antibody staining at defined points or terminal endpoints

  • Correlate HXT7 levels with individual cell lifespan data

Integration with Nutrient Signaling Pathways:

• Co-immunoprecipitation with Aging Regulators:

  • Use HXT7 antibodies to pull down associated complexes

  • Probe for interaction with longevity regulators (e.g., Sir2, Tor1)

  • Compare interaction profiles between young and aged cells

• Phosphorylation Status Analysis:

  • Immunoprecipitate HXT7 from young and aged populations

  • Analyze phosphorylation patterns using phospho-specific antibodies

  • Connect phosphorylation state with transporter activity and lifespan

Caloric Restriction Models:

• Differential Expression Analysis:

  • Compare HXT7 levels between normal and calorie-restricted cultures

  • Quantify using immunoblotting and flow cytometry

  • Determine whether HXT7 upregulation (similar to low-glucose response) mediates CR benefits

• Genetic Manipulation Approaches:

  • Create strains with constitutive HXT7 expression using promoter engineering (similar to the deletion series approach)

  • Assess lifespan extension relative to wildtype

  • Use antibodies to confirm consistent expression throughout lifespan

Metabolic Impact Assessment:

• Glucose Flux Correlation:

  • Measure glucose uptake rates in young versus aged cells

  • Correlate with HXT7 protein levels determined by antibody-based methods

  • Link transport activity to known aging biomarkers

• ROS Production Analysis:

  • Study whether altered HXT7 levels impact reactive oxygen species production

  • Combine antibody staining for HXT7 with ROS-sensitive dyes

  • Investigate mechanistic connections between glucose transport and oxidative stress

These approaches leverage antibody-based detection of HXT7 to uncover fundamental connections between glucose transport dynamics and the aging process in yeast, potentially revealing conserved mechanisms relevant to metabolic health and longevity in higher organisms.

What are the key considerations when selecting or developing new HXT7 antibodies for specialized research applications?

When selecting or developing new HXT7 antibodies for specialized research applications, researchers should consider these critical factors:

Epitope Selection Strategy:

• Sequence Analysis Approach:

  • Perform bioinformatic analysis of HXT7 compared to other HXT family members

  • Identify unique regions with minimal homology to related transporters

  • Select epitopes that are surface-accessible in the native protein

  • Consider both N-terminal and C-terminal regions, which typically show greater divergence among membrane transporters

• Structural Considerations:

  • Target epitopes in extracellular or cytoplasmic domains rather than transmembrane regions

  • Utilize predicted protein structure to identify accessible loops

  • Consider conformational changes that might occur with different glucose concentrations

Antibody Format Selection:

• Application-Driven Choice:

  • Polyclonal antibodies: Better for general detection and capturing multiple epitopes

  • Monoclonal antibodies: Superior for specific epitope recognition and reproducibility

  • Recombinant antibodies: Offer consistent renewable source without batch variation

  • Nanobodies/single-domain antibodies: Provide access to sterically restricted epitopes

• Modification-Specific Antibodies:

  • Develop antibodies against known or predicted post-translational modifications

  • Create phospho-specific antibodies for regulatory sites

  • Generate conformation-specific antibodies that distinguish active/inactive states

Validation Requirements:

• Comprehensive Specificity Testing:

  • Test against HXT deletion panel (especially Δhxt7)

  • Perform Western blotting, immunoprecipitation, and immunofluorescence validation

  • Verify using strains with variable HXT7 expression (similar to the promoter deletion series)

  • Confirm reactivity patterns match known glucose-dependent expression profiles

• Functional Validation:

  • Ensure antibodies don't interfere with transporter function

  • Verify detection in native membrane environments

  • Test performance under different sample preparation conditions

Production Considerations:

• Immunization Strategy:

  • Use multiple immunization approaches (peptide vs. recombinant protein fragments)

  • Consider DNA immunization for conformationally-relevant epitopes

  • Implement prime-boost strategies to enhance response

• Screening Methodology:

  • Develop screening assays that match intended application

  • Include negative controls (Δhxt7 lysates)

  • Screen against related HXT proteins to eliminate cross-reactive clones

Documentation Requirements:

• Provide detailed information on the epitope used

• Include comprehensive validation data showing specificity

• Document performance across different applications and conditions

• Report optimized protocols for specific research applications

Future-Oriented Design:

• Include features that enable emerging technologies (site-specific labeling options)

• Develop paired antibodies that recognize different epitopes for proximity assays

• Consider humanized versions for potential therapeutic applications

These considerations ensure that newly developed HXT7 antibodies will provide reliable tools for advancing research on glucose transport mechanisms, building upon the fundamental understanding of HXT7 regulation established in previous studies .